TG Therapeutics Price Target Raised to $55.00/Share From $49.00 by HC Wainwright & Co.

Dow Jones01:51 · Ratings

TG Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones01:51 · Ratings

Goldman Sachs Maintains Neutral on TG Therapeutics, Raises Price Target to $22

Benzinga01:26 · Ratings

A Quick Look at Today's Ratings for TG Therapeutics(TGTX.US), With a Forecast Between $38 to $55

Futu NewsNov 5 21:00 · Ratings

TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceNov 5 18:41

TG Therapeutics Boosts Revenue Outlook Amidst Growth

TipRanksNov 5 12:13